Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/23/2023 17:00 EST Earnings Call Q4 2022 -- -- --
02/23/2023 -- Results Q4 2022 -- -0.65 --
11/02/2022 08:30 EST Earnings Call Q3 2022 -- -- --
11/02/2022 -- Results Q3 2022 -0.42 -0.38 -11.94%
08/04/2022 17:00 EST Earnings Call Q2 2022 -- -- --
08/04/2022 -- Results Q2 2022 -0.15 -0.33 53.87%
05/05/2022 17:00 EST Earnings Call Q1 2022 -- -- --
05/05/2022 -- Results Q1 2022 -0.62 -0.51 -21.83%
*Estimated Date/Time

Earnings

Next Report Date 02/23/2023
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/02/2022
Beat/Miss Upgrade
Return Since 21.72%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.
URL https://www.inogen.com
Investor Relations URL https://investor.inogen.com/
HQ State/Province California
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Blend
Next Earnings Release Feb. 23, 2023
Last Earnings Release Nov. 02, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
67.55%
77.28%
4.27%
-44.97%
-34.61%
-23.90%
-42.03%
31.91%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
7.86%
42.55%
63.02%
29.19%
-44.06%
77.80%
12.23%
13.35%
3.84%
--
--
--
--
136.2%
71.93%
15.30%
-8.90%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-85.21%
26.67%
-23.93%
70.05%
-17.52%
10.42%
-13.60%
-24.30%
-79.98%
55.47%
As of February 03, 2023.

Profile

Edit
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.
URL https://www.inogen.com
Investor Relations URL https://investor.inogen.com/
HQ State/Province California
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Blend
Next Earnings Release Feb. 23, 2023
Last Earnings Release Nov. 02, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
QCSGX 6.349M USD 1.09%
AFMCX 471542.0 USD 0.97%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter INGN Tweets